ORIC PHARMACEUTICALS INC (ORIC) Stock Income Statement
NASDAQ:ORIC - Nasdaq - US68622P1093 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 146.62M | 142.90M | 110.78M | 91.77M | 78.87M | |||
| Research and Development | 116.75M | 114.07M | 85.17M | 66.68M | 56.86M | |||
| Selling, General, and Administrative Expenses | 29.87M | 28.82M | 25.61M | 25.09M | 22.01M | |||
| Operating Income | -146.62M | -142.90M | -110.78M | -91.77M | -78.87M | |||
| Interest Income/Expense | 13.77M | 15.05M | 10.08M | 2.65M | 140.00K | |||
| Other Income/Expense | N/A | N/A | N/A | 0.00 | 20.00K | |||
| Non Recurring Items | N/A | N/A | 0.00 | N/A | 0.00 | |||
| Income Before Taxes | -132.86M | -127.85M | -100.70M | -89.12M | -78.72M | |||
| Income Tax | N/A | 0.00 | N/A | N/A | N/A | |||
| Net Income | -132.86M | -127.85M | -100.70M | -89.12M | -78.72M | |||
| EBITDA | -145.47M | -141.79M | -109.75M | -90.80M | -77.97M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.88 | -1.83 | -1.96 | -2.25 | -2.07 | |||
| Non GAAP EPS | -1.87 | -1.82 | -1.96 | -2.25 | -2.07 | |||
| Statistics | ||||||||
All data in USD